medigraphic.com
SPANISH

Revista Cubana de Medicina

ISSN 1561-302X (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 4

<< Back Next >>

Rev cubana med 2020; 59 (4)

Fusarium peritonitis in a patient on home peritoneal dialysis

Álvarez GY, Bohorques RR
Full text How to cite this article

Language: Spanish
References: 15
Page: 1-5
PDF size: 288.31 Kb.


Key words:

fungal peritonitis, home peritoneal dialysis, rare complication.

ABSTRACT

Introduction: Fungal peritonitis is an infrequent but serious complication for a patient on home peritoneal dialysis.
Objective: To describe a case of fungal peritonitis in a patient on continuous ambulatory peritoneal dialysis (CAPD).
Methods: A 53-year-old male patient is reported, with a history of arterial hypertension, 9 years on continuous outpatient peritoneal dialysis, moderate protein-energy malnutrition. During his treatment, he had several episodes of bacterial peritonitis, exit-site infections, and repositioning of a peritoneal catheter with an extruded cuff. We worked with his antecedents, clinical status, etiological agent and treatment. The diagnosis was established by the presence of cloudy peritoneal fluid, cell count higher than 100 leukocytes / ul, and culture with the presence of the filamentous fungus.
Results: In December 2017, he was diagnosed with fusarium peritonitis, with no leukocytosis or anemia, he did present hypoalbuminemia. A culture was performed on the wall of the room where the patient had his exchanges and filamentous fungus was found. Initially, treatment started with vancomycin and ceftazidime, followed by amikacin. Finally, after having a culture showed the pathogen, treatment with itraconazole started. Unfortunately the patient died 20 days later.
Conclusions: This research analyzes clinical and microbiological aspects of fusarium peritonitis, which are poorly understood in home peritoneal dialysis.


REFERENCES

  1. Li PK. ISPD Peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481-508.

  2. Wilkie M. The 2016 ISPD update on prevention and treatment of peritonitis-grading the evidence. Perit Dial Int. 2016;36(5):469-70.

  3. Álvarez González Y, Bohorques Rodríguez R, Martínez Torres A, Ballard Álvarez Y, Pérez Canepa S, Gutiérrez García F. Peritonitis en un programa de diálisis peritoneal domiciliaria en el Instituto de Nefrología, 2007-2011. Rev cubana med. 2012[acceso: 14/05/2018];5(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232012000200003

  4. Bhowmik D. Concerns regarding the ISPD guidelines/recommendations for peritonitis due to mycobacteria. Perit Dial Int. 2011;31(3):363-4.

  5. Szeto CC, Li PK. Concerns regarding ISPD recommendations for peritonitis in relation to imipenem/cilastatin-In reply. Perit Dial Int. 2017;37(5):585.

  6. Higuchi C. Peritonitis in peritoneal dialysis patients in Japan: A 2013 retrospective questionnaire survey of Japanese Society for Peritoneal Dialysis member institutions. Renal Replace Therap. 2016;2(1):2.

  7. Bohorques R, Álvarez Y, Martínez A, Ballard Y, Pérez S, Gutiérrez F. Use of Home Peritoneal Dialysis by Cuba's Nephrology Institute, 2007-2012. Medicc Review. 2015[acceso: 14/05/2018];17(2). Disponible en: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=64409

  8. Wolk DM, Dunne WM. New technologies in clinical microbiology. J Clin Microbiol. 2011;49(9 Suppl):S62-7.

  9. Muthucumarana K. The relationship between presentation and the time of initial administration of antibiotics with outcomes of peritonitis in peritoneal dialysis patients: The PROMPT study. Kidney Int Rep. 2016;1(2):65-72.

  10. Kaduchak G, Ward MD. System and method for acoustic focusing hardware and implementations. Current Protocols. 2009[acceso: 14/05/2018]. Disponible en: https://currentprotocols.onlinelibrary.wiley.com/doi/abs/10.1002/0471142956.cy0122s49

  11. Kirkup BC. Culture-independence for surveillance and epidemiology. Pathogens. 2013;2(3):556-70.

  12. Mulroney KT. Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae. Sci Rep. 2017;7(1):1903.

  13. Auricchio S, Giovenzana ME, Pozzi M. Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation. Clin Kidney J. 2018;11(6):874-80. https://doi.org/10.1093/ckj/sfy045

  14. Prasad N, Gupta A. Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int. 2005; 25:207-22.

  15. Pers C, Tvedegaard E, Christensen JJ, Bangsborg J. Capnocytophaga cynodegmi peritonitis in a peritoneal dialysis patient. J Clin Microbiol. 2007;45(11):3844-6.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev cubana med. 2020;59